Remove tag reimbursement
article thumbnail

bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies

Pharmaceutical Technology

Spark Therapeutics’ Luxturna, indicated for inherited retinal disease (IRD), was the first gene therapy to be approved, in 2017, with a price tag of $850,000 for each eye. Prior to bluebird's approvals, there were only two FDA-approved gene therapies for inherited conditions on the market.

FDA 115
article thumbnail

Risk-sharing agreements are growing at a rate of 24%

Pharmaceutical Technology

This is not the first treatment to come with a high price tag. Partly in response to such drugs, risk-sharing agreements (RSAs) have increased in popularity and aim to mitigate the risks of including high-cost drugs on reimbursement lists and healthcare plans.

Marketing 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

Reimbursement has been a major obstacle in the EU for expensive gene therapies, including bluebird bio’s beta-thalassemia therapy Zynteglo. million price tag. The post Can gene therapies for haemophilia defend their high price tags? After its approval, bluebird had set Zynteglo’s price at roughly EUR1.6 million ($1.8

Safety 111
article thumbnail

bluebird unveils $2.8m price for gene therapy Zynteglo on FDA approval

pharmaphorum

The US approval comes three years after Zynteglo (betibeglogene autotemcel) was approved for the same indication in Europe, and subsequently withdrawn after bluebird concluded that it wasn’t possible to build a commercially viable business for the gene therapy as the pricing and reimbursement environment there was too “hostile.”

FDA 52
article thumbnail

A broad range of unmet needs remains in the immuno-oncology space

Pharmaceutical Technology

IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000. Patients and healthcare facilities across markets often experience difficulties getting these agents reimbursed. Cost-related unmet needs also scored highly.

article thumbnail

How Much Does SEO Cost?

Healthcare Success

What’s more, if they do a poor job of “fixing” 404 errors, title tags, or meta descriptions across your site, it could damage your site authority, trustworthiness, and brand reputation. And, if you want to rank for “best plastic surgeon in Beverly Hills?” it’s likely to be significantly more expensive and take more time to achieve.

article thumbnail

Advanced therapies and the high-profile pricing dilemma

pharmaphorum

Yet, in the space of a decade, certain treatments have come along that have raised important questions over the future of treatment, reimbursement, and the value of the quality of life for patients. However, with a price tag of €1.58 How to navigate the new climate. At more than $2.1

Medicine 129